Medicinova (MNOV) Non Operating Investment Income (2010)

Medicinova's (MNOV) quarterly Non Operating Investment Income came in at $27747.0 in Q4 2010, up 103.19% on a QoQ basis from -$869767.0 in Q3 2010.

Medicinova (MNOV) Non Operating Investment Income (2010) Analysis & Trends

Medicinova (MNOV) has 1 years of Non Operating Investment Income data on file, last reported at $27747.0 in Q4 2010.

On a quarterly basis, Non Operating Investment Income changed N/A year-over-year to $27747.0 in Q4 2010; TTM through Sep 2011 was -$842020.0, a N/A change from a year earlier, with the FY2010 full-year figure at -$785478.0, down 353.18% from the prior year.
Non Operating Investment Income for Q4 2010 stood at $27747.0, up from -$869767.0 in the prior quarter.
Over the last five years, Non Operating Investment Income for MNOV reached as high as $64018.0 in Q2 2010 and fell as low as -$869767.0 in Q3 2010.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non Operating Investment Income (Qtr)
1	Oculis Holding AG	66,621.14 Bn	66,620.85 Bn	-	-
2	Nanobiotix	1,915.18 Bn	1,915.11 Bn	-	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-	-
4	BeOne Medicines	471.27 Bn	466.48 Bn	1.35 Bn	-
5	Vertex Pharmaceuticals	121.81 Bn	114.57 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	69.58 Bn	60.82 Bn	3.31 Bn	-
7	Belite Bio	62.72 Bn	62.72 Bn	-	-
8	Argenx Se	55.51 Bn	50.33 Bn	1.41 Bn	-
9	Revolution Medicines	37.35 Bn	37.35 Bn	-	-
10	Medicinova	64.76 Mn	64.76 Mn	4,754.00	-

Download Data